3-O-Sulfogalactosylceramide (d18:1/20:0)
|
Basic information |
| Metabolite name | 3-O-Sulfogalactosylceramide (d18:1/20:0) |
 | HMDB0012315 |
 |
C06125 |
 |
24779583 |
| Synonyms | SL d18:1/20:0 |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | 3-O-Sulfogalactosylceramide (d18:1/20:0) |
| HMDB0012315 |
|
C06125 |
|
24779583 |
| Synonyms | SL d18:1/20:0 |
| No. of studies | 2 |
|
Relationship between 3-O-Sulfogalactosylceramide (d18:1/20:0) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M123 | Type3 | rTMS group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M123 | Type3 | rTMS group vs. control group | Striatum | Wistar rat | Down |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |